I-131-CLR1404
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for I-131-CLR1404, covering 2010-05-04 to 2015-02-26. Get the full timeline:
Most recent: Clinical Trial Update: Dose Escalation Study of I-131-CLR1404 in Subjects With Cancer That Does Not Respond to Treatment or Has Returned [Phase 1]